- Location
- 800-262-392
- MON-SUN 08:00AM-08:00PM - Emergency Department 24/7
- تعرف علي موقعنا
- 800-262-392
- 8:00 صباحًا حتى 8:00 مساءً - من الإثنين إلى الأحد - قسم الطوارئ 24/7
- Location
- 800-262-392
- LUN - DIM 08:00AM - 08:00PM Service d'urgence 24/7
Dr Deborah Mukherji completed her advanced specialty training in Medical Oncology at Guys and St Thomas’s NHS Foundation Trust, London UK and was awarded a Post-Graduate Diploma in Oncology from the Institute of Cancer Research, University of London in 2011. On completion of her specialty training Dr Mukherji joined the Royal Marsden Hospital London where she worked in clinical research and drug development with a focus on prostate cancer. In June 2015 Dr Mukherji was awarded a post-graduate diploma in Global Clinical Research from Harvard Medical School supported by a scholarship from the Dubai-Harvard Foundation. In June 2016 Dr Mukherji was elected as a Fellow of the Royal College of Physicians UK.
In 2012 Dr Mukherji joined the faculty of the American University of Beirut and has been actively involved patient care, clinical research and the teaching of medical students and junior doctors. Dr Mukherji co-chairs the Advanced Prostate Cancer Consensus Conference Middle East Satellite Meeting and recently published resource-stratified consensus recommendations for the region in the World Journal of Urology. Dr Mukherji is a member of the European Society of Medical Oncology (ESMO) Faculty for prostate cancer and is on the scientific committee for the ESMO World Congress on Gastrointestinal Cancer. Dr Mukherji is also a member of the American Society of Clinical Oncology (ASCO) and was invited to give educational lectures at the 2017 and 2019 ASCO annual meetings.
Dr Mukherji is an advocate for Women in Oncology, writes on gender equity issues for ASCO Connection and is the senior author of the first report on female oncologists in the MENA region with colleagues from the Arab Medical Association Against Cancer (AMAAC). Dr Mukherji has recently been appointed as a commissioner for the Lancet Commission for Women and Cancer investigating the intersection between gender and cancer care, research and leadership and was recently awarded the Women in Oncology Award MENA 2021 by the Emirates Oncology Society.
Dr Mukherji has over 130 peer-reviewed publications with over 2500 citations and an h-index of 27 (Google Scholar September 2021). A full list of publications can be found using the following link:
https://www.ncbi.nlm.nih.gov/myncbi/18cDANk8DJ-ke/bibliography/public/
Yusuf A, Sarfati D, Booth CM, Pramesh CS, Lombe D, Aggarwal A, Bhoo-Pathy N, Tsunoda A, Vanderpuye V, Kutluk T, Sullivan A, Mukherji D, Mutebi M, van Hemelrijck M, Sullivan R; COVID-19 and Cancer Global Taskforce. Cancer and COVID-19 vaccines: a complex global picture. Lancet Oncol. 2021 Jun;22(6):749-751. doi: 10.1016/S1470-2045(21)00244-8. Epub 2021 Apr 27. PMID: 33930324, PMCID: PMC8078890
Wells JC, Sharma S, Del Paggio JC, Hopman WM, Gyawali B, Mukherji D, Hammad N, Pramesh CS, Aggarwal A, Sullivan R, Booth CM. An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries. JAMA Oncol. 2021 Mar 1;7(3):379-385. doi: 10.1001/jamaoncol.2020.7478. PMID: 33507236, PMCID: PMC7844695
Shamseddine A, Zeidan YH, El Husseini Z, Kreidieh M, Al Darazi M, Turfa R, Kattan J, Khalifeh I, Mukherji D, Temraz S, Alqasem K, Amarin R, Al Awabdeh T, Deeba S, Jamali F, Mohamad I, Elkhaldi M, Daoud F, Al Masri M, Dabous A, Hushki A, Jaber O, et al. Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma. Radiat Oncol. 2020 Oct 7;15(1):233. doi: 10.1186/s13014-020-01673-6. PMID: 33028346, PMCID: PMC7542723
Mukherji D, Youssef B, Dagher C, El-Hajj A, Nasr R, Geara F, Rabah D, Al Dousari S, Said R, Ashou R, Wazzan W, Jabbour M, Farha G, Al Hamdani N, Al Hallaq Y, Ghazal H, Dbouk H, Bachir B, El Khoury C, Sakr G, Hussain HK, Sayyid K, et al. Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations. World J Urol. 2020 Mar;38(3):681-693. doi: 10.1007/s00345-019-02872-x. PMID: 31297628, PMCID: PMC7064460
Mukherji D, Omlin A, Pezaro C. Living Longer and Better with Advanced Prostate Cancer. Eur Urol. 2020 Sep;78(3):358-359. doi: 10.1016/j.eururo.2020.05.020. Epub 2020 Jun 15. PMID: 32553618
Cheaito K, Bahmad HF, Jalloul H, Hadadeh O, Msheik H, El-Hajj A, Mukherji D, Al-Sayegh M, Abou-Kheir W. Epidermal Growth Factor Is Essential for the Maintenance of Novel Prostate Epithelial Cells Isolated From Patient-Derived Organoids. Front Cell Dev Biol. 2020 Oct 29;8:571677. doi: 10.3389/fcell.2020.571677. PMID: 33195205, PMCID: PMC7658326
Abou-Kheir W, Mukherji D, Hadadeh O, Saleh E, Bahmad HF, Kanso M, Khalifeh M, Shamseddine A, Tamraz S, Jaafar R, Dagher C, Khalifeh I, Faraj W. CYR61/CCN1 expression in resected pancreatic ductal adenocarcinoma: A retrospective pilot study of the interaction between the tumors and their surrounding microenvironment. Heliyon. 2020 May 3;6(5):e03842. doi: 10.1016/j.heliyon.2020.e03842. PMID:32395647, PMCID: PMC7205742
Abdul-Sater Z, Menassa M, El Achi N, Abdul-Khalek RA, Abu-Sittah G, Mukherji D. Strengthening capacity for cancer research in conflict settings: key informant insights from the Middle East. Ecancermedicalscience. 2020 Dec 10;14:1153. doi: 10.3332/ecancer.2020.1153. PMID: 33574898,PMCID: PMC7864685
Abdul-Sater Z, Shamseddine A, Taher A, Fouad F, Abu-Sitta G, Fadhil I, Saab R, Sullivan R, Adib SM, Saleh S, Mukherji D; ICRIM. Cancer Registration in the Middle East, North Africa, and Turkey: Scope and Challenges. JCO Glob Oncol. 2021 Jul;7:1101-1109. doi: 10.1200/GO.21.00065. PMID: 34236931
